Connection

JASON KIMATA to Animals

This is a "connection" page, showing publications JASON KIMATA has written about Animals.
Connection Strength

0.487
  1. Challenges and strategies for the eradication of the HIV reservoir. Curr Opin Immunol. 2016 10; 42:65-70.
    View in: PubMed
    Score: 0.031
  2. Subversion of Cell Cycle Regulatory Mechanisms by HIV. Cell Host Microbe. 2015 Jun 10; 17(6):736-40.
    View in: PubMed
    Score: 0.029
  3. Stepping toward a macaque model of HIV-1 induced AIDS. Viruses. 2014 Sep 25; 6(9):3643-51.
    View in: PubMed
    Score: 0.027
  4. A variant macaque-tropic human immunodeficiency virus type 1 is resistant to alpha interferon-induced restriction in pig-tailed macaque CD4+ T cells. J Virol. 2013 Jun; 87(12):6678-92.
    View in: PubMed
    Score: 0.025
  5. Absence of XMRV in peripheral blood mononuclear cells of ARV-treatment na?ve HIV-1 infected and HIV-1/HCV coinfected individuals and blood donors. PLoS One. 2012; 7(2):e31398.
    View in: PubMed
    Score: 0.023
  6. Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1. J Virol. 2011 Apr; 85(8):3767-79.
    View in: PubMed
    Score: 0.021
  7. Relative replication capacity of phenotypic SIV variants during primary infections differs with route of inoculation. Retrovirology. 2010 Oct 13; 7:88.
    View in: PubMed
    Score: 0.021
  8. Changes in simian immunodeficiency virus reverse transcriptase alleles that appear during infection of macaques enhance infectivity and replication in CD4+ T cells. Virology. 2008 Jan 05; 370(1):184-93.
    View in: PubMed
    Score: 0.017
  9. ICAM-3 influences human immunodeficiency virus type 1 replication in CD4(+) T cells independent of DC-SIGN-mediated transmission. Virology. 2007 Aug 01; 364(2):383-94.
    View in: PubMed
    Score: 0.016
  10. HIV-1 fitness and disease progression: insights from the SIV-macaque model. Curr HIV Res. 2006 Jan; 4(1):65-77.
    View in: PubMed
    Score: 0.015
  11. The increased replicative capacity of a late-stage simian immunodeficiency virus mne variant is evident in macrophage- or dendritic cell-T-cell cocultures. Virology. 2004 Oct 01; 327(2):307-17.
    View in: PubMed
    Score: 0.014
  12. Domains of macaque DC-SIGN essential for capture and transfer of simian immunodeficiency virus. Virology. 2004 Jun 20; 324(1):194-203.
    View in: PubMed
    Score: 0.013
  13. Pro-inflammatory feedback loops define immune responses to pathogenic Lentivirus infection. Genome Med. 2024 02 05; 16(1):24.
    View in: PubMed
    Score: 0.013
  14. Antiviral potency of long-acting islatravir subdermal implant in SHIV-infected macaques. J Control Release. 2024 02; 366:18-27.
    View in: PubMed
    Score: 0.013
  15. Long-acting refillable nanofluidic implant confers protection against SHIV infection in nonhuman primates. Sci Transl Med. 2023 06 28; 15(702):eadg2887.
    View in: PubMed
    Score: 0.013
  16. Capture and transfer of simian immunodeficiency virus by macaque dendritic cells is enhanced by DC-SIGN. J Virol. 2002 Dec; 76(23):11827-36.
    View in: PubMed
    Score: 0.012
  17. Highly pathogenic simian immunodeficiency virus mne variants that emerge during the course of infection evolve enhanced infectivity and the ability to downregulate CD4 but not class I major histocompatibility complex antigens. J Virol. 2002 Jul; 76(13):6425-34.
    View in: PubMed
    Score: 0.012
  18. Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern. Vaccine. 2022 06 09; 40(26):3655-3663.
    View in: PubMed
    Score: 0.012
  19. Clearance of HIV-1 or SIV reservoirs by promotion of apoptosis and inhibition of autophagy: Targeting intracellular molecules in cure-directed strategies. J Leukoc Biol. 2022 11; 112(5):1245-1259.
    View in: PubMed
    Score: 0.011
  20. Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate. Protein Expr Purif. 2022 02; 190:106003.
    View in: PubMed
    Score: 0.011
  21. SARS-CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice. Hum Vaccin Immunother. 2021 08 03; 17(8):2356-2366.
    View in: PubMed
    Score: 0.011
  22. IP-10 and CXCR3 signaling inhibit Zika virus replication in human prostate cells. PLoS One. 2020; 15(12):e0244587.
    View in: PubMed
    Score: 0.011
  23. Clearance of HIV infection by selective elimination of host cells capable of producing HIV. Nat Commun. 2020 08 13; 11(1):4051.
    View in: PubMed
    Score: 0.010
  24. Efficient pre-catalytic conformational change of reverse transcriptases from SAMHD1 non-counteracting primate lentiviruses during dNTP incorporation. Virology. 2019 11; 537:36-44.
    View in: PubMed
    Score: 0.010
  25. Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression. Nat Med. 1999 May; 5(5):535-41.
    View in: PubMed
    Score: 0.009
  26. Coreceptor specificity of temporal variants of simian immunodeficiency virus Mne. J Virol. 1999 Feb; 73(2):1655-60.
    View in: PubMed
    Score: 0.009
  27. A lymph node-derived cytopathic simian immunodeficiency virus Mne variant replicates in nonstimulated peripheral blood mononuclear cells. J Virol. 1998 Jan; 72(1):245-56.
    View in: PubMed
    Score: 0.009
  28. The cytopathicity of a simian immunodeficiency virus Mne variant is determined by mutations in Gag and Env. J Virol. 1997 Oct; 71(10):7629-39.
    View in: PubMed
    Score: 0.008
  29. Efficient Transduction of Human and Rhesus Macaque Primary T Cells by a Modified Human Immunodeficiency Virus Type 1-Based Lentiviral Vector. Hum Gene Ther. 2017 03; 28(3):271-285.
    View in: PubMed
    Score: 0.008
  30. The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1. J Virol. 2016 Dec 01; 90(23):10642-10659.
    View in: PubMed
    Score: 0.008
  31. HIV replication in conjunction with granzyme B production by CCR5+ memory CD4 T cells: Implications for bystander cell and tissue pathologies. Virology. 2014 Aug; 462-463:175-88.
    View in: PubMed
    Score: 0.007
  32. Vpx is critical for SIVmne infection of pigtail macaques. Retrovirology. 2012 Apr 24; 9:32.
    View in: PubMed
    Score: 0.006
  33. GPI-anchored single chain Fv--an effective way to capture transiently-exposed neutralization epitopes on HIV-1 envelope spike. Retrovirology. 2010 Oct 06; 7:79.
    View in: PubMed
    Score: 0.005
  34. A decrease in albumin in early SIV infection is related to viral pathogenicity. AIDS Res Hum Retroviruses. 2009 Apr; 25(4):433-40.
    View in: PubMed
    Score: 0.005
  35. Heavily glycosylated, highly fit SIVMne variants continue to diversify and undergo selection after transmission to a new host and they elicit early antibody dependent cellular responses but delayed neutralizing antibody responses. Virol J. 2008 Aug 04; 5:90.
    View in: PubMed
    Score: 0.004
  36. Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy. J Virol. 2007 Nov; 81(22):12145-55.
    View in: PubMed
    Score: 0.004
  37. Immunogenicity and protective efficacy of Gag/Pol/Env vaccines derived from temporal isolates of SIVmne against cognate virus challenge. J Med Primatol. 2007 Aug; 36(4-5):254-65.
    View in: PubMed
    Score: 0.004
  38. Functional and antigenic characterization of human, rhesus macaque, pigtailed macaque, and murine DC-SIGN. J Virol. 2001 Nov; 75(21):10281-9.
    View in: PubMed
    Score: 0.003
  39. Identification of a simian immunodeficiency virus reverse transcriptase variant with enhanced replicational fidelity in the late stage of viral infection. J Biol Chem. 2001 Jun 29; 276(26):23624-31.
    View in: PubMed
    Score: 0.003
  40. Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVMne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication, cytopathicity, or CCR-5 coreceptor recognition. J Virol. 1998 Jan; 72(1):209-17.
    View in: PubMed
    Score: 0.002
  41. Progression to AIDS in macaques is associated with changes in the replication, tropism, and cytopathic properties of the simian immunodeficiency virus variant population. Virology. 1995 Mar 10; 207(2):528-42.
    View in: PubMed
    Score: 0.002
  42. Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc Natl Acad Sci U S A. 1995 Feb 14; 92(4):1057-61.
    View in: PubMed
    Score: 0.002
  43. Replication of human immunodeficiency virus 1 and Moloney murine leukemia virus is inhibited by different heteroatom-containing analogs of myristic acid. Proc Natl Acad Sci U S A. 1989 Nov; 86(22):8655-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.